Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968197 · ClinicalTrials.gov registry record · NA
Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
A NA study of Balance Disorder, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT04968197: Completed NA study of Balance Disorder, sponsored by Mayo Clinic.
NCT04968197 is a NA study of Balance Disorder that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968197, a NA study of Balance Disorder, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a vestibular interventional approach using stochastic vestibular stimulation (SVS) through a small, lightweight device, and a comfortable electrode set on the back of the head that stimulates the vestibular system and produces immediate improvements in balance, gait, and overall vestibular function for patients will balance disorder.
Primary Outcome
Change in balance performance during balance testing by measuring the center of gravity sway (degrees per second) across tested levels of GVR amplitude and control condition.
Conditions Studied
Interventions
- DEVICE Vestibular Intervention via Portable Electrical Stimulator (VIPES) system
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04968197 record still lists
NCT04968197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Balance Disorder appearing as the primary indexed condition, and to 1 intervention - of which Vestibular Intervention via Portable Electrical Stimulator (VIPES) system is the first listed.
NCT04968197 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04968197 about?
NCT04968197 is a clinical study titled "Vestibular Intervention Via Portable Electrical Stimulator (VIPES)". The purpose of this study is to develop a vestibular interventional approach using stochastic vestibular stimulation (SVS) through a small, lightweight device, and a comfortable electrode set on the back of the head that stimulates the vestibular system and produces immediate improvements in balance...
What is the current status of trial NCT04968197?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-09-01. Estimated completion is 2023-12-31.
What conditions does trial NCT04968197 study?
This clinical trial studies the following conditions: Balance Disorder.
What interventions are being tested in trial NCT04968197?
The interventions under investigation include: Vestibular Intervention via Portable Electrical Stimulator (VIPES) system (DEVICE).
Who is sponsoring clinical trial NCT04968197?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04968197 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04968197's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI